KENIA CASTRO: Open Payments
NPI 1124237524 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 78 payments from 15 companies in 2025. Trend: 2023 $1,626 · 2024 $1,613 · 2025 $1,807
Food & beverage: $1,807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $573 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $304 |
| Lundbeck LLC | 8 | $173 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| E.R. Squibb & Sons, L.L.C. | 3 | $86 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Corium, LLC | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Collegium Pharmaceutical, Inc. | 3 | $67 |
| Tris Pharma Inc | 3 | $63 |
Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, Auvelity, Azstarys, HETLIOZ, Jornay PM.
Industry payments across FL — which companies pay providers there.
